Another father-son fight on March 29?

Published: 2007-03-21 07:00:00

Updated: 2007-03-21 07:00:00

Following Dong-A Pharmaceutical's shareholders' meeting to be scheduled on March 29, some market watchers are wondering whether the firm is going into another round of the father-son dispute for control.

Dong-A Pharmaceutical Chairman Kang Shin-ho and his second son Kang Moon-seok have been en...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK